60 SECONDS

摘要

A DRUG that finds and fights cancer wherever it is in the body has been approved in the US for the first time. Pembrolizumab helps the body's immune system fight cancers that carry particular signatures on the surface of their cells, regardless of where the tumour is or where the cancer began. Last week, the US Food and Drug Administration approved the drug for treating people who test positive for either of two signatures.